Home
| Databases
| WorldLII
| Search
| Feedback
Generic Top Level Domain Name (gTLD) Decisions |
ClickPharmacy.com, Inc. v. Server Central
Network a/k/a Customer Owned Domain
Claim
Number: FA0308000190512
Complainant is ClickPharmacy.com, Inc., Miami, FL
(“Complainant”) represented by Michael
C. Cesarano of Akerman Senterfitt. Respondent is Server Central Network a/k/a Customer Owned Domain, Chicago, IL
(“Respondent”).
REGISTRAR
AND DISPUTED DOMAIN NAME
The
domain name at issue is <click-pharmacy.com>, registered with Enom,
Inc.
The
undersigned certifies that she has acted independently and impartially and that
to the best of her knowledge, she has no known
conflict in serving as Panelist
in this proceeding. Hon. Carolyn Marks Johnson sits as Panelist.
Complainant
submitted a Complaint to the National Arbitration Forum (the "Forum")
electronically on August 22, 2003; the
Forum received a hard copy of the
Complaint August 25, 2003.
On
August 28, 2003, Enom, Inc. confirmed by e-mail to the Forum that the domain
name <click-pharmacy.com> is registered with Enom, Inc. and that
Respondent is the current registrant of the name. Enom, Inc. verified that
Respondent is bound
by the Enom, Inc. registration agreement and has thereby
agreed to resolve domain-name disputes brought by third parties in accordance
with ICANN's Uniform Domain Name Dispute Resolution Policy (the
"Policy").
On
August 28, 2003, a Notification of Complaint and Commencement of Administrative
Proceeding (the "Commencement Notification"),
setting a deadline of
September 17, 2003, by which Respondent could file a Response to the Complaint,
was transmitted to Respondent
via e-mail, post and fax, to all entities and
persons listed on Respondent's registration as technical, administrative and
billing
contacts, and to postmaster@click-pharmacy.com by e-mail.
Having
received no Response from Respondent, using the same contact details and
methods as were used for the Commencement Notification,
the Forum transmitted
to the parties a Notification of Respondent Default.
On
September 26, 2003, pursuant to Complainant's request to have the dispute
decided by a single-member Panel, the Forum appointed
Hon. Carolyn Marks
Johnson as Panelist.
Having
reviewed the communications records, the Administrative Panel (the
"Panel") finds that the Forum has discharged its
responsibility under
Paragraph 2(a) of the Rules for Uniform Domain Name Dispute Resolution Policy
(the "Rules") "to
employ reasonably available means calculated
to achieve actual notice to Respondent."
Therefore, the Panel may issue its decision based on the documents
submitted and in accordance with the ICANN Policy, ICANN Rules,
the Forum's
Supplemental Rules and any rules and principles of law that the Panel deems
applicable, without the benefit of any Response
from Respondent.
Complainant
requests that the domain name be transferred from Respondent to Complainant.
A. Complainant makes the following assertions:
1. The domain name registered by Respondent,
<click-pharmacy.com>, is confusingly similar to Complainant’s
CLICKPHARMACY.COM mark.
2. Respondent has no rights to or legitimate
interests in the <click-pharmacy.com> domain name.
3. Respondent registered and used the <click-pharmacy.com>
domain name in bad faith.
B. Respondent failed to submit a Response in this
proceeding.
Complainant,
ClickPharmacy.com, Inc., established in this proceeding that it owns the
CLICKPHARMACY.COM mark, as registered on the
Prinicpal Register of the U.S.
Patent and Trademark Office December 5, 2000. Under this mark, Complainant
(through its agent, Kramer
Laboratories) operates a website at the
<clickpharmacy.com> domain name through which Internet users can order
pharmaceutical
products online.
Complainant has
operated this business under the CLICKPHARMACY.COM mark since 1998, and its
website is recognized by the National
Association of Board of Pharmacy as one
of twelve Verified Internet Pharmacy Practice Site (VIPPS certified website) in
the United
States.
Respondent,
Server Central Network a/k/a Customer Owned Domain, registered the <click-pharmacy.com>
domain name February 13, 2003. Respondent is not licensed or authorized to use
Complainant’s CLICKPHARMACY.COM mark for any purpose.
Respondent operates a
website that offers pharmaceutical products at the disputed domain name.
Paragraph 15(a)
of the Rules instructs this Panel to "decide a complaint on the basis of
the statements and documents submitted
in accordance with the Policy, these
Rules and any rules and principles of law that it deems applicable."
In view of
Respondent's failure to submit a Response, the Panel shall decide this
administrative proceeding on the basis of Complainant's
undisputed
representations pursuant to paragraphs 5(e), 14(a) and 15(a) of the Rules and
will draw such inferences as the Panel considers
appropriate pursuant to
paragraph 14(b) of the Rules.
Paragraph 4(a)
of the Policy requires that Complainant must prove each of the following three
elements to obtain an order that a domain
name should be cancelled or
transferred:
(1) the domain name registered by Respondent
is identical to or confusingly similar to a trademark or service mark in which
Complainant
has rights; and
(2) Respondent has no rights or legitimate
interests in respect of the domain name; and
(3) the domain name has been registered and
is being used in bad faith.
Complainant
established in this proceeding that it has rights in the CLICKPHARMACY.COM mark
through registration of the mark on the
Principal Register of the U.S. Patent
and Trademark Office and by use in commerce. See Men’s Wearhouse, Inc. v.
Wick, FA 117861 (Nat. Arb. Forum Sept. 16, 2002) (“Under U.S. trademark
law, registered marks hold a presumption that they are inherently
distinctive
and have acquired secondary meaning”); see also Janus Int’l Holding Co. v. Rademacher, D2002-0201 (WIPO Mar. 5,
2002) (finding that Panel decisions have held that registration of a mark is prima facie evidence of validity, which
creates a rebuttable presumption that the mark is inherently distinctive. Respondent has the burden of refuting this
assumption).
The domain name
registered by Respondent, <click-pharmacy.com>, is confusingly similar to Complainant’s
CLICKPHARMACY.COM mark. Without the addition of the hyphen between the words
CLICK and PHARMACY.COM
in Complainant’s mark, the domain name would be
identical to the mark. The mere
addition of a well-placed hyphen does not prevent a finding of confusing
similarity under the Policy. See Chernow Communications Inc. v. Kimball, D2000-0119 (WIPO May 18,
2000) ( “the use or absence of punctuation marks, such as hyphens, does not
alter the fact that a name
is identical to a mark"); see also Easyjet
Airline Co. Ltd. v. Harding, D2000-0398 (WIPO June 22, 2000) (finding it
obvious that the domain name <easy-jet.net> was virtually
identical to Complainant's EASYJET mark and therefore that they are confusingly
similar).
Accordingly, the
Panel finds that the <click-pharmacy.com> domain name is confusingly similar to Complainant’s CLICKPHARMACY.COM mark
under Policy ¶ 4(a)(i).
Complainant
established in this proceeding that it has rights to and legitimate interests
in the mark contained within the domain
name that Respondent registered. Respondent uses the <click-pharmacy.com>
domain name to operate an online pharmaceutical company, just as
Complainant uses its CLICKPHARMACY.COM mark to operate an online
pharmaceutical
company at the <clickpharmacy.com> domain name. The difference between
Complainant and Respondent’s use is that
Complainant registered the
CLICKPHARMACY.COM mark and began using the mark as early as 1998. Respondent is
using Complainant’s mark,
without authorization by Complainant, to compete with
Complainant. Respondent’s use is not a “bona fide” offering of goods or
services
at the disputed domain name. Similarly, Respondent’s use is not a
legitimate noncommercial or fair use of the domain name. Thus,
Respondent’s
activities do not fall within the ambit of Policy ¶¶ 4(c)(i) and (iii). See
Ameritrade Holdings Corp. v. Polanski, FA 102715 (Nat. Arb. Forum Jan. 11,
2002) (finding that Respondent’s use of the disputed domain name to redirect
Internet users
to a financial services website, which competed with
Complainant, was not a bona fide offering of goods or services); see also
Clear Channel Communications, Inc. v. Beaty Enters., FA 135008 (Nat. Arb.
Forum Jan. 2, 2003) (finding that Respondent, as a competitor of Complainant,
had no rights or legitimate interests
in a domain name that utilized Complainant’s
mark for its competing website).
As Complainant
is granted the exclusive right to use the CLICKPHARMACY.COM mark in the United
States for certain pharmaceutical goods
and services through its registration
of the mark on the Principal Register of the U.S. Patent and Trademark Office,
and as Respondent
has not come forward to explain how Respondent could be
considered to be “commonly known by” Complaint’s mark or the <click-pharmacy.com>
domain name, the Panel finds that Respondent may not avail itself of Policy
¶4(c)(ii). See Tercent Inc. v. Yi, FA 139720
(Nat. Arb. Forum Feb. 10, 2003) (stating “nothing in Respondent’s WHOIS
information implies that Respondent is ‘commonly
known by’ the disputed domain
name” as one factor in determining that Policy ¶ 4(c)(ii) does not apply); see
also RMO, Inc. v.
Burbridge, FA 96949
(Nat. Arb. Forum May 16, 2001) (interpreting Policy ¶ 4(c)(ii) "to require
a showing that one has been commonly known
by the domain name prior to
registration of the domain name to prevail").
Accordingly, the
Panel finds that Respondent does not have rights or legitimate interests in the
<click-pharmacy.com> domain
name under Policy ¶ 4(a)(ii).
Complainant
alleges that Respondent registered and used the disputed domain name in bad
faith. Respondent uses the disputed domain
name to operate an online business
that provides nearly identical services to those provided by Complainant. In
providing these services,
Respondent chose to identify itself with a confusingly
similar variant of Complainant’s registered CLICKPHARMACY.COM mark. Respondent
is thereby creating a likelihood of confusion as to sponsorship or affiliation
of its website with Complainant’s <clickpharmacy.com>
domain name and
CLICKPHARMACY.COM mark. As Respondent is capitalizing on this likelihood of
confusion for commercial gain, its activities
run afoul of the provisions of
Policy ¶ 4(b)(iv), and evidence bad faith registration and use of the disputed
domain name. See Computerized Sec. Sys., Inc. v. Hu, FA 157321 (Nat.
Arb. Forum June 23, 2003) (finding that Respondent’s use of the
<saflock.com> domain name to offer goods competing
with Complainant’s
illustrates Respondent’s bad faith registration and use of the domain name,
evidence of bad faith registration
and use pursuant to Policy 4(b)(iv)); see
also Am. Online, Inc. v. Fu,
D2000-1374 (WIPO Dec. 11, 2000) (finding that Respondent intentionally
attempted to attract Internet users to his website for commercial
gain by
creating a likelihood of confusion with Complainant’s mark and offering the
same chat services via his website as Complainant).
The Panel thus
finds that Respondent registered and used the <click-pharmacy.com> domain name in bad faith, and that Policy ¶
4(a)(iii) is satisfied.
Having
established all three elements required under the ICANN Policy, the Panel
concludes that relief shall be GRANTED.
Accordingly, it is Ordered that the <click-pharmacy.com>
domain name be TRANSFERRED from Respondent to Complainant.
Hon. Carolyn Marks Johnson, Panelist
Dated: October 8, 2003.
WorldLII:
Copyright Policy
|
Disclaimers
|
Privacy Policy
|
Feedback
URL: http://www.worldlii.org/int/other/GENDND/2003/967.html